Microbiologist Maurice Hilleman foresaw the global spread of a novel influenza strain in 1957. His vaccine saved hundreds of thousands of lives.

Injecting the seasonal flu vaccine directly into clumps of malignant cells recruits immune cells to confront the cancer.

Antibiotics disrupt the immune response to the influenza vaccine in people who haven’t recently had exposure to the virus or immunization.

Numerous experimental vaccines that aim to provide multi-season protection are in human studies.

Vaccination reduced the risk of death by two-thirds for children with no other health problems.  

The vaccine shows better-than-expected effectiveness against the most common and most virulent strain of influenza in children under 9 years old.

A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 

The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 

Adding an adjuvant to stimulate both innate and adaptive immunity, researchers boost the effectiveness of an influenza A vaccine in mice.